- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
13
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
13 companies
Ascendis Pharma
Market Cap: US$11.9b
Operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Denmark, rest of Europe, North America, and internationally.
ASND
US$199.59
7D
0.6%
1Y
34.1%
Alnylam Pharmaceuticals
Market Cap: US$60.5b
Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.
ALNY
US$451.73
7D
-3.7%
1Y
65.4%
Insmed
Market Cap: US$30.6b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$144.78
7D
-0.7%
1Y
93.1%
Eli Lilly
Market Cap: US$686.5b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$760.13
7D
0.7%
1Y
-16.0%
BeOne Medicines
Market Cap: US$36.0b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$332.20
7D
5.8%
1Y
68.4%
Exelixis
Market Cap: US$10.5b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$40.44
7D
7.3%
1Y
50.8%
AbbVie
Market Cap: US$382.0b
A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.
ABBV
US$220.81
7D
4.3%
1Y
14.4%
Exact Sciences
Market Cap: US$10.0b
Provides cancer screening and diagnostic test products in the United States and internationally.
EXAS
US$52.38
7D
-4.4%
1Y
-24.3%
Neurocrine Biosciences
Market Cap: US$14.0b
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.
NBIX
US$142.73
7D
1.0%
1Y
19.1%
Teva Pharmaceutical Industries
Market Cap: US$21.4b
Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA
US$18.38
7D
-6.1%
1Y
2.8%
Natera
Market Cap: US$24.0b
A diagnostics company, provides molecular testing services worldwide.
NTRA
US$175.43
7D
3.3%
1Y
38.0%
Medpace Holdings
Market Cap: US$13.8b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$497.83
7D
4.4%
1Y
37.8%
Viatris
Market Cap: US$11.1b
Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.
VTRS
US$9.62
7D
-6.1%
1Y
-19.2%